Insider plans to sell 2,181 TVTX shares

Reporting person filed a Form 144 reporting the proposed sale of 2,181 shares of common stock on 05/04/2026 following the vesting of Performance Restricted Stock Units.

Rhea-AI Filing Summary

Reporting person filed a Form 144 reporting the proposed sale of 2,181 shares of common stock on 05/04/2026 following the vesting of Performance Restricted Stock Units. The filing also lists recent open-market dispositions by Christopher Cline: 1,014 shares for $43,206.54, 7,239 shares for $303,522.58, 9 shares for $369.63, and 65 shares for $1,875.25.

Insights

Equity Capital Markets Analyst

Form 144 records a planned affiliate sale of vested RSUs and lists recent small dispositions.

The filing states the sale relates to Performance Restricted Stock Unit Vesting and specifies 05/04/2026 as the vesting/sale date for 2,181 shares. This is a routine liquidity event typically associated with compensation vesting.

Cash flow recipients and exact sale mechanics are not stated in the excerpt; subsequent trade reports would show execution details.

Key Figures

Planned sale: 2,181 shares Recent sale: 1,014 shares Recent sale: 7,239 shares +2 more

5 metrics

Planned sale 2,181 shares Performance RSU vesting on 05/04/2026

Recent sale 1,014 shares 04/15/2026 for $43,206.54

Recent sale 7,239 shares 04/14/2026 for $303,522.58

Recent sale 9 shares 04/14/2026 for $369.63

Recent sale 65 shares 04/13/2026 for $1,875.25

Key Terms

Form 144, Performance Restricted Stock Unit Vesting, Issuer

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Performance Restricted Stock Unit Vesting financial

"Performance Restricted Stock Unit Vesting | Issuer"

Issuer regulatory

"Performance Restricted Stock Unit Vesting | Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the TVTX Form 144 report?

The Form 144 reports a proposed sale of 2,181 shares tied to Performance Restricted Stock Unit vesting on 05/04/2026. It also lists recent sales by Christopher Cline totaling several thousand shares and specified dollar amounts.

Who is the reporting person on the TVTX filing?

The filing names Christopher Cline as the reporting person associated with the listed dispositions. The filing shows his recent sales and the planned sale of shares following RSU vesting on 05/04/2026.

How many shares did Christopher Cline recently sell?

Recent dispositions in the past three months include 1,014 shares for $43,206.54, 7,239 shares for $303,522.58, 9 shares for $369.63, and 65 shares for $1,875.25, as listed in the filing.

Are the proceeds recipient and sale methods specified?

The excerpt ties the 2,181-share item to an RSU vesting event but does not specify who receives cash or the exact sale method. The text labels the item as "Issuer" and "Compensation," implying compensation-related issuance.

Does the Form 144 indicate trading restrictions or limits?

The provided excerpt does not state any beneficial ownership limits or trading-plan language. It records the vesting-driven sale listing and prior open-market dispositions; no additional restrictions are shown in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/05/2026 - 07:48 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001943192
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Travere Therapeutics, Inc.
SEC File Number	001-36257
Address of Issuer	3611 Valley Centre Dr. Suite 300 San Diego CALIFORNIA 92130
Phone	888-969-7879
Name of Person for Whose Account the Securities are To Be Sold	Christopher Cline
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney 3 Edison Drive Alpharetta GA 30005	2181	101743.65	92992905	05/05/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/04/2026	Performance Restricted Stock Unit Vesting	Issuer			2181	05/04/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Christopher Cline 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	04/15/2026	1014	43206.54
Christopher Cline 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	04/14/2026	7239	303522.58
Christopher Cline 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	04/14/2026	9	369.63
Christopher Cline 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	04/13/2026	65	1875.25

144: Remarks and Signature

Remarks	Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested performance restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person.
Date of Notice	05/05/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Elizabeth E. Reed as attorney-in-fact for Christopher Cline
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)